[131I]-SGMIB Anti-HER2 VHH1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [131I]-SGMIB Anti-HER2 VHH1, covering 2019-07-18 to 2019-07-18. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Tumor Imaging Potential of [131I]-SGMIB Anti-HER2 VHH1 in Healthy Volunteers and Breast Cancer Patients [Phase 1]